Key Focus Areas This Week: Jobs, Home Prices, Nike, McCormick, Conagra, and More
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy PHR?
Source: Barron's
Market Performance: Equities have declined for the fifth consecutive week, with the Nasdaq Composite index dropping 3.2% and the S&P 500 falling 2.1%.
Correction Status: The Nasdaq has officially entered correction territory, indicating a drop of 10% or more from its recent high.
Percentage Decline: The Nasdaq is currently down 12.6% from its record close achieved in late October.
Overall Trend: The ongoing slump reflects a broader trend of declining equity markets over the past several weeks.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHR
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 10.980
Low
24.00
Averages
29.09
High
35.00
Current: 10.980
Low
24.00
Averages
29.09
High
35.00
About PHR
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Phreesia Set to Announce Q4 Earnings on March 30
- Earnings Announcement Schedule: Phreesia (PHR) is set to announce its Q4 earnings on March 30 after market close, with a consensus EPS estimate of $0.32, reflecting a substantial year-over-year increase of 390.9%, indicating a significant improvement in the company's profitability.
- Revenue Expectations: The anticipated revenue for Q4 is $126.63 million, representing a 15.5% year-over-year growth, which highlights the company's robust growth in the market and sustained customer demand, potentially boosting investor confidence.
- Historical Performance Review: Over the past year, Phreesia has not missed EPS estimates, achieving a 100% beat on revenue estimates, showcasing the company's strong performance in revenue generation, which may attract more investor interest.
- Estimate Revision Dynamics: In the last three months, there have been no upward revisions to EPS estimates, with two downward adjustments, while revenue estimates saw one upward revision and two downward adjustments, indicating a cautious market sentiment regarding the company's future performance, which could impact short-term stock price volatility.
See More
Multiple Companies Set to Report Earnings
- Progress Software Earnings Outlook: Progress Software Corporation (PRGS) is expected to report earnings per share of $1.18, reflecting a 10.28% increase year-over-year, indicating the company's consistent ability to exceed market expectations, which may further boost investor confidence.
- Phreesia Earnings Surge: Phreesia, Inc. (PHR) forecasts earnings per share of $0.09, representing a staggering 181.82% increase compared to the same quarter last year, highlighting the company's strong performance in the medical information systems sector, potentially attracting more investor interest.
- Virgin Galactic Earnings Forecast: Virgin Galactic Holdings, Inc. (SPCE) anticipates earnings per share of -$1.12, although still negative, this marks a 55.73% improvement year-over-year, suggesting recovery potential in the aerospace sector, which may influence market perceptions of its future growth.
- HireQuest Earnings Decline: HireQuest, Inc. (HQI) expects earnings per share of $0.12, down 36.84% from the same quarter last year, reflecting challenges faced in the staffing industry, which could negatively impact its stock price.
See More
Phreesia Q4 Earnings Release Forecast
- Earnings Release Date: Phreesia, Inc. is set to release its Q4 earnings on March 30, with investors closely monitoring the performance to assess the company's future growth potential.
- Earnings Per Share Expectation: Analysts anticipate earnings per share to drop to 7 cents, a significant decline from 18 cents last year, indicating challenges in the company's profitability.
- Market Reactions: Latest ratings reveal mixed opinions among analysts regarding Phreesia, with some expressing optimism about its future performance while others voice concerns over its profitability, potentially impacting investor confidence.
- Industry Context: Amid increasing competition in the healthcare technology sector, Phreesia must implement effective strategies to navigate market pressures and ensure its ongoing competitiveness in the industry.
See More
Key Focus Areas This Week: Jobs, Home Prices, Nike, McCormick, Conagra, and More
Market Performance: Equities have declined for the fifth consecutive week, with the Nasdaq Composite index dropping 3.2% and the S&P 500 falling 2.1%.
Correction Status: The Nasdaq has officially entered correction territory, indicating a drop of 10% or more from its recent high.
Percentage Decline: The Nasdaq is currently down 12.6% from its record close achieved in late October.
Overall Trend: The ongoing slump reflects a broader trend of declining equity markets over the past several weeks.
See More
Phreesia Named One of Becker's Top Places to Work in Healthcare for 2026
- Employee Recognition: Phreesia has been named one of Becker's Healthcare's Top Places to Work in Healthcare for 2026, marking its second inclusion, which highlights the company's ongoing investment in employee benefits and professional development, enhancing engagement and retention.
- Remote Work Advantage: As a fully remote company, Phreesia focuses on connection and support among teams, ensuring employees can engage in meaningful work tied to their mission by offering competitive compensation, flexible time off, and home-office support.
- Enhanced Employee Benefits: The company provides generous parental benefits and resources for ongoing professional growth, ensuring that employees receive support in both personal and professional aspects, thereby improving overall employee experience and satisfaction.
- Industry Impact: In 2024, Phreesia enabled approximately 170 million patient visits, accounting for 1 in 7 visits across the U.S., and through its patient-driven digital solutions, it drives efficiency and improves healthcare outcomes, further solidifying its leadership position in the healthcare industry.
See More
Phreesia Shares Surge 5.1% Driven by Investor Optimism
- Significant Price Increase: Phreesia's stock surged 5.1% in the last trading session to close at $11.77, with trading volume significantly exceeding normal levels, indicating heightened market confidence in its future performance.
- Investor Confidence Boost: Pale Fire Capital SE purchased 1,602,505 shares of Phreesia between March 17 and 19 for approximately $18.3 million, increasing its total holdings to 7,648,829 shares, which further bolstered market optimism about the company.
- Strong Earnings Expectations: Phreesia is expected to report quarterly earnings of $0.09 per share, reflecting a year-over-year increase of 181.8%, with revenues projected at $126.37 million, up 15.2% from the previous year, showcasing the company's growth potential.
- Market Focus: Although the consensus EPS estimate has remained unchanged over the past 30 days, research indicates a strong correlation between earnings estimate revisions and stock price movements, prompting investors to closely monitor Phreesia's future performance.
See More
Phreesia Set to Announce Q4 Earnings on March 30
- Earnings Announcement Schedule: Phreesia (PHR) is set to announce its Q4 earnings on March 30 after market close, with a consensus EPS estimate of $0.32, reflecting a substantial year-over-year increase of 390.9%, indicating a significant improvement in the company's profitability.
- Revenue Expectations: The anticipated revenue for Q4 is $126.63 million, representing a 15.5% year-over-year growth, which highlights the company's robust growth in the market and sustained customer demand, potentially boosting investor confidence.
- Historical Performance Review: Over the past year, Phreesia has not missed EPS estimates, achieving a 100% beat on revenue estimates, showcasing the company's strong performance in revenue generation, which may attract more investor interest.
- Estimate Revision Dynamics: In the last three months, there have been no upward revisions to EPS estimates, with two downward adjustments, while revenue estimates saw one upward revision and two downward adjustments, indicating a cautious market sentiment regarding the company's future performance, which could impact short-term stock price volatility.
See More
Multiple Companies Set to Report Earnings
- Progress Software Earnings Outlook: Progress Software Corporation (PRGS) is expected to report earnings per share of $1.18, reflecting a 10.28% increase year-over-year, indicating the company's consistent ability to exceed market expectations, which may further boost investor confidence.
- Phreesia Earnings Surge: Phreesia, Inc. (PHR) forecasts earnings per share of $0.09, representing a staggering 181.82% increase compared to the same quarter last year, highlighting the company's strong performance in the medical information systems sector, potentially attracting more investor interest.
- Virgin Galactic Earnings Forecast: Virgin Galactic Holdings, Inc. (SPCE) anticipates earnings per share of -$1.12, although still negative, this marks a 55.73% improvement year-over-year, suggesting recovery potential in the aerospace sector, which may influence market perceptions of its future growth.
- HireQuest Earnings Decline: HireQuest, Inc. (HQI) expects earnings per share of $0.12, down 36.84% from the same quarter last year, reflecting challenges faced in the staffing industry, which could negatively impact its stock price.
See More
Phreesia Q4 Earnings Release Forecast
- Earnings Release Date: Phreesia, Inc. is set to release its Q4 earnings on March 30, with investors closely monitoring the performance to assess the company's future growth potential.
- Earnings Per Share Expectation: Analysts anticipate earnings per share to drop to 7 cents, a significant decline from 18 cents last year, indicating challenges in the company's profitability.
- Market Reactions: Latest ratings reveal mixed opinions among analysts regarding Phreesia, with some expressing optimism about its future performance while others voice concerns over its profitability, potentially impacting investor confidence.
- Industry Context: Amid increasing competition in the healthcare technology sector, Phreesia must implement effective strategies to navigate market pressures and ensure its ongoing competitiveness in the industry.
See More
Key Focus Areas This Week: Jobs, Home Prices, Nike, McCormick, Conagra, and More
Market Performance: Equities have declined for the fifth consecutive week, with the Nasdaq Composite index dropping 3.2% and the S&P 500 falling 2.1%.
Correction Status: The Nasdaq has officially entered correction territory, indicating a drop of 10% or more from its recent high.
Percentage Decline: The Nasdaq is currently down 12.6% from its record close achieved in late October.
Overall Trend: The ongoing slump reflects a broader trend of declining equity markets over the past several weeks.
See More
Phreesia Named One of Becker's Top Places to Work in Healthcare for 2026
- Employee Recognition: Phreesia has been named one of Becker's Healthcare's Top Places to Work in Healthcare for 2026, marking its second inclusion, which highlights the company's ongoing investment in employee benefits and professional development, enhancing engagement and retention.
- Remote Work Advantage: As a fully remote company, Phreesia focuses on connection and support among teams, ensuring employees can engage in meaningful work tied to their mission by offering competitive compensation, flexible time off, and home-office support.
- Enhanced Employee Benefits: The company provides generous parental benefits and resources for ongoing professional growth, ensuring that employees receive support in both personal and professional aspects, thereby improving overall employee experience and satisfaction.
- Industry Impact: In 2024, Phreesia enabled approximately 170 million patient visits, accounting for 1 in 7 visits across the U.S., and through its patient-driven digital solutions, it drives efficiency and improves healthcare outcomes, further solidifying its leadership position in the healthcare industry.
See More
Phreesia Shares Surge 5.1% Driven by Investor Optimism
- Significant Price Increase: Phreesia's stock surged 5.1% in the last trading session to close at $11.77, with trading volume significantly exceeding normal levels, indicating heightened market confidence in its future performance.
- Investor Confidence Boost: Pale Fire Capital SE purchased 1,602,505 shares of Phreesia between March 17 and 19 for approximately $18.3 million, increasing its total holdings to 7,648,829 shares, which further bolstered market optimism about the company.
- Strong Earnings Expectations: Phreesia is expected to report quarterly earnings of $0.09 per share, reflecting a year-over-year increase of 181.8%, with revenues projected at $126.37 million, up 15.2% from the previous year, showcasing the company's growth potential.
- Market Focus: Although the consensus EPS estimate has remained unchanged over the past 30 days, research indicates a strong correlation between earnings estimate revisions and stock price movements, prompting investors to closely monitor Phreesia's future performance.
See More
